| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | E2_1-01-8860 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | E2_1-02-8861 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | E2_2-01-8862 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | E2_2-02-8863 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | E2_3-01-8864 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | E2_3-02-8865 | Treatment:17-β-estradiol | AU |
| Reversed phase POSITIVE ION MODE | control_1-01-8852 | Treatment:Control | AU |
| Reversed phase POSITIVE ION MODE | control_1-02-8853 | Treatment:Control | AU |
| Reversed phase POSITIVE ION MODE | control_2-01-8854 | Treatment:Control | AU |
| Reversed phase POSITIVE ION MODE | control_2-02-8855 | Treatment:Control | AU |
| Reversed phase POSITIVE ION MODE | control_3-01-8856 | Treatment:Control | AU |
| Reversed phase POSITIVE ION MODE | control_3-02-8857 | Treatment:Control | AU |
Return to study ST003029 main page
Download data matrix(Estrogen-mediated inhibition of purine metabolism and cell cycle arrest as a novel therapeutic approach in colorectal cancer cells Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|